Management of prolactinomas in Brazil: An electronic survey

Pituitary

Volumn 13, Issue 3, 2010, Pages 199-206

  Vilar, Lucio ^a   Naves, Luciana Ansaneli ^b   Casulari, Luiz Augusto ^b   Azevedo, Monalisa Ferreira ^b   Albuquerque, José Luciano ^a   Serfaty, Fabiano Marcel ^c   Pinho Barbosa, Flavia R ^c   De Oliveira Jr , Antonio Ribeiro ^d   Montenegro, Renan Magalhães ^e   Montenegro Jr , Renan Magalhaães ^e   Ramos, Alberto José Santos ^f   Dos Santos Faria, Manuel ^g   Musolino, Nina Rosa C ^h   Gadelha, Monica R ^c   Boguszewski, Cesar Luiz ^h   Bronstein, Marcello D ^h  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^f Campina Grande Federal University   (Brazil)

^g FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bromocriptine; Cabergoline; Hyperprolactinemia; Prolactinomas

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; PROLACTIN;

ARTICLE; BRAZIL; BREAST FEEDING; CONTROLLED STUDY; DIAGNOSTIC REASONING; E-MAIL; HUMAN; ONLINE SYSTEM; PATIENT ASSESSMENT; PATIENT CARE; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; PUERPERIUM; QUESTIONNAIRE; SCREENING TEST; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

BRAZIL; BROMOCRIPTINE; DATA COLLECTION; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; PREGNANCY; PROLACTINOMA;

EID: 77955924997     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-010-0217-8     Document Type: Article

References (40)

1. A Colao 2009 Pituitary tumours: the prolactinoma Best Pract Res Clin Endocrinol Metab 23 575 596 10.1016/j.beem.2009.05.003 1:CAS:528: DC%2BD1MXhsV2ltbbK 19945024
2. FF Casanueva ME Molitch JA Schlechte R Abs V Bonert MD Bronstein, et al. 2006 Guidelines of the pituitary society for the diagnosis and management of prolactinomas Clin Endocrinol (Oxf) 65 265 273 10.1111/j.1365-2265.2006.02562.x (Pubitemid 44079693)
3. T Mancini FF Casanueva A Giustina 2008 Hyperprolactinemia and prolactinomas Endocrinol Metab Clin North Am 37 67 99 10.1016/j.ecl.2007.10.013 1:CAS:528:DC%2BD1cXktVWlsbw%3D 18226731 (Pubitemid 351146629)
4. M Kars F Roelfsema JA Romijn AM Pereira 2006 Malignant prolactinoma: case report and review of the literature Eur J Endocrinol 155 523 534 10.1530/eje.1.02268 1:CAS:528:DC%2BD28XhtFKjtb%2FF 16990651 (Pubitemid 44636871)
5. MP Gillam ME Molitch G Lombardi A Colao 2006 Advances in the treatment of prolactinomas Endocr Rev 27 485 534 10.1210/er.2005-9998 1:CAS:528: DC%2BD28XpvVelurY%3D 16705142 (Pubitemid 44213229)
6. JA Schlechte 2007 Long-term management of prolactinomas J Clin Endocrinol Metab 92 2861 2865 10.1210/jc.2007-0836 1:CAS:528:DC%2BD2sXptl2iu7k%3D 17682084 (Pubitemid 47236339)
7. L Vilar MC Freitas LA Naves LA Casulari M Azevedo R Montenegro Jr, et al. 2008 Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients J Endocrinol Invest 31 436 444 1:CAS:528:DC%2BD1cXpslGru7w%3D 18560262
8. J Verhelst R Abs D Maiter M Vandeweghe B Velkeniers J Mockel, et al. 1999 Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients J Clin Endocrinol Metab 84 2518 2522 10.1210/jc.84.7.2518 1:CAS:528: DyaK1MXks1ansr4%3D 10404830
9. A Colao A Di Sarno ML Landi P Cappabianca R Pivonello R Volpe, et al. 2000 Macroprolactinoma shrinkage during cabergoline treatment is greater in naive than in patients pre-treated with other dopamine agonists: a prospective study in 110 patients J Clin Endocrinol Metab 85 2247 2252 10.1210/jc.85.6.2247 1:CAS:528:DC%2BD3cXlsVCjsrw%3D 10852458 (Pubitemid 32269250)
10. J Webster G Piscitelli A Polli CI Ferrari I Ismail MF Scanlon 1994 A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea N Engl J Med 331 904 909 10.1056/ NEJM199410063311403 1:STN:280:DyaK2czlvFGksg%3D%3D 7915824 (Pubitemid 24299871)
11. L Vilar LA Naves M Gadelha 2003 Pitfalls in the diagnosis of hyperprolactinemia Arq Brasil Endocrinol Metab 47 347 357
12. E Toldy Z Löcsei I Szabolcs MI Góth P Kneffel D Szöke GL Kovács 2003 Macroprolactinemia: the consequences of a laboratory pitfall Endocrine 22 267 273 10.1385/ENDO:22:3:267 1:CAS:528:DC%2BD2cXhtVCjtbs%3D 14709800 (Pubitemid 38183703)
13. A Glezer CR Soares JG Vieira D Giannella-Neto MT Ribela V Goffin MD Bronstein 2006 Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay J Clin Endocrinol Metab 91 1048 1055 10.1210/jc.2005-1831 1:CAS:528:DC%2BD28Xis1Cmurw%3D 16384849 (Pubitemid 43357779)
14. J Gibney TP Smith TJ McKenna 2005 The impact on clinical practice of routine screening for macroprolactin J Clin Endocrinol Metab 90 3927 3932 10.1210/jc.2004-2234 1:CAS:528:DC%2BD2MXmtlCisbc%3D 15811931 (Pubitemid 41058153)
15. A Alfonso KI Rieniets RA Vigersky 2006 Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia Endocr Pract 12 275 280 16772199
16. S Vallette-Kasic I Morange-Ramos A Selim G Gunz S Morange A Enjalbert, et al. 2002 Macroprolactinemia revisited: a study on 106 patients J Clin Endocrinol Metab 87 581 588 10.1210/jc.87.2.581 1:CAS:528:DC%2BD38XhsVSjurk%3D 11836289 (Pubitemid 34158222)
17. MW Strachan WL Teoh AC Don-Wauchope J Seth M Stoddart GJ Beckett 2003 Clinical and radiological features of patients with macroprolactinaemia Clin Endocrinol (Oxf) 59 339 346 10.1046/j.1365-2265.2003.01852.x (Pubitemid 37046987)
18. L Vilar E Moura V Canadas A Gusmão R Campos E Leal, et al. 2007 Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia Arq Brasil Endocrinol Metab 51 86 91
19. J Schlechte K Dolan B Sherman F Chapler A Luciano 1989 The natural history of untreated hyperprolactinemia: a prospective analysis J Clin Endocrinol Metab 68 412 418 10.1210/jcem-68-2-412 1:STN:280:DyaL1M7jvFOmsw%3D%3D 2918052
20. CM March OA Kletzky V Davajan J Teal M Weiss ML Apuzzo 1981 Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas Am J Obstet Gynecol 139 835 844 1:STN:280:DyaL3M7lslCktA%3D%3D 7193977
21. MC Koppelman MJ Jaffe KG Rieth RC Caruso DL Loriaux 1984 Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases Ann Intern Med 100 115 121 1:STN:280:DyaL2c7gt1KrtQ%3D%3D 6537879
22. DA Sisam JP Sheehan LR Sheeler 1987 The natural history of untreated microprolactinomas Fertil Steril 48 67 71 1:STN:280:DyaL2s3kslChtQ%3D%3D 3595916
23. VQ Passos JJ Souza NR Musolino MD Bronstein 2002 Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal J Clin Endocrinol Metab 87 3578 3582 10.1210/jc.87.8.3578 1:CAS:528: DC%2BD38XmtF2gsL4%3D 12161478 (Pubitemid 34879499)
24. A Colao A Di Sarno P Cappabianca C Di Somma R Pivonello G Lombardi 2003 Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia N Engl J Med 349 2023 2033 10.1056/NEJMoa022657 1:CAS:528:DC%2BD3sXptFKmur4%3D 14627787 (Pubitemid 37448925)
25. M Biswas J Smith D Jadon P McEwan DA Rees LM Evans, et al. 2005 Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas Clin Endocrinol (Oxf) 63 26 31 10.1111/j.1365-2265.2005. 02293.x 1:STN:280:DC%2BD2MzhsFCjuw%3D%3D (Pubitemid 40966398)
26. A Colao A Di Sarno E Guerra R Pivonello P Cappabianca F Caranci, et al. 2007 Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy Clin Endocrinol (Oxf) 67 426 433 10.1111/j.1365-2265. 2007.02905.x 1:CAS:528:DC%2BD2sXhtFCgtb3I (Pubitemid 47283843)
27. J Kharlip R Salvatori G Yenokyan GS Wand 2009 Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy J Clin Endocrinol Metab 94 2428 2436 10.1210/jc.2008-2103 1:CAS:528: DC%2BD1MXosl2ksrY%3D 19336508
28. AT Nelson Jr HS Tucker Jr DP Becker 1984 Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas J Neurosurg 61 577 580 10.3171/jns.1984.61.3.0577 6747696
29. L Vilar LA Naves MC Freitas M Lima V Canadas JL Albuquerque, et al. 2007 Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia Minerva Endocrinol 32 79 86 1:STN:280:DC%2BD2szktlCgsw%3D%3D 17557033
30. ME Molitch 1985 Pregnancy and the hyperprolactinemic woman N Engl J Med 312 1364 1370 10.1056/NEJM198505233122106 1:STN:280:DyaL2M7ovVWhuw%3D%3D 3887166
31. MD Bronstein 2005 Prolactinomas and pregnancy Pituitary 8 31 38 10.1007/s11102-005-5083-4 16411066 (Pubitemid 44680083)
32. E Robert L Musatti G Piscitelli CI Ferrari 1996 Pregnancy outcome after treatment with the ergot derivative, cabergoline Reprod Toxicol 10 333 337 10.1016/0890-6238(96)00063-9 1:CAS:528:DyaK28XkvVOrtb4%3D 8829257 (Pubitemid 26310263)
33. E Ciccarelli S Grottoli P Razzore D Gaia A Bertagna S Cirillo, et al. 1997 Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy J Endocrinol Invest 20 547 551 1:CAS:528:DyaK2sXnvF2nsLc%3D 9413809
34. A Colao R Abs DG Bárcena P Chanson W Paulus DL Kleinberg 2008 Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study Clin Endocrinol (Oxf) 68 66 71 10.1111/j.1365-2265. 2007.03000.x 1:CAS:528:DC%2BD1cXisVyns7c%3D (Pubitemid 350243483)
35. SA Imran E Ur DB Clarke 2007 Managing prolactin-secreting adenomas during pregnancy Can Fam Physician 53 653 658 17872715
36. MD Bronstein LR Salgado NR de Castro Musolino 2002 Medical management of pituitary adenomas: the special case of management of the pregnant woman Pituitary 5 99 107 10.1023/A:1022364514971 1:CAS:528:DC%2BD3sXhtVOlu78%3D 12675507 (Pubitemid 36336015)
37. AB Shewchuk GD Adamson P Lessard C Ejrin 1980 The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea Am J Obstet Gynecol 136 659 666 1:STN:280:DyaL3c7islGgug%3D%3D 7355945
38. U Holmgren G Bergstrand K Hagenfeldt S Werner 1986 Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumour growth Acta Endocrinol (Copenh) 111 452 459 1:STN:280:DyaL283htV2muw%3D%3D
39. A Zarate ES Canales M Alger G Forsbach 1979 The effect of pregnancy and lactation on pituitary prolactin-secreting tumours Acta Endocrinol (Copenh) 92 407 412 1:STN:280:DyaL3c%2FosVerug%3D%3D
40. MD Bronstein NR Musolino CS Cardim R Marino Jr 1988 Outcome of 52 pregnancies in hyperprolactinemic women Rev Bras Ginecol Obstet 10 175 178